NCT06631079 2026-01-08
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors
NEC Bio B.V
Phase 1/2 Active not recruiting
Clinical Trials
3 trialsNCT06220318 2025-11-28
Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors
Fujian Haixi Pharmaceuticals Co., Ltd.
Phase 1/2 Active not recruiting
NCT05379946 2025-04-08
Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors
InventisBio Co., Ltd
Phase 1/2 Active not recruiting